FDA approval opens up new markets for innovative endoscope

Independently developed by the Chongqing Jinshan Science and Technology (Group) Co Ltd (CJST), the OMOM capsule endoscope, a new kind of non-invasive and painless intelligent diagnostic instrument for digestive diseases, will now be available in an increased number of countries following approval by the Food and Drug Administration (FDA) of the United States.

As one of CJST's key products, the OMOM capsule endoscope is suitable for the diagnosis of digestive diseases and for use in physical examinations. Compared with traditional endoscopy techniques, the OMOM capsule endoscope has the advantages of wider vision, accurate operation and high levels of patient safety. It is also said to offer less discomfort for patients compared to other systems, whilst having unique applications in small intestinal diagnosis usage.

The OMOM capsule endoscope system comprises four units - an intelligent capsule, an image recorder, a video workstation and a handheld wireless monitor. The patient simply needs to ingest the intelligent capsule, which will move within the patient's digestive tract via gastrointestinal muscle motility. It will then record a video of the digestive tract wall so that the doctor can detect images and control the image parameters of the capsule in real time. Ultimately, the intelligent capsule will evacuate the body naturally.